Avanos Medical (AVNS) FCF Margin (2013 - 2026)

Avanos Medical has disclosed FCF Margin across 14 years of filings, most recently posting 9.11% for Q1 2026.

• FCF Margin for Q1 2026 came in at 9.11%, down 2045.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.24% (down 1307.0% YoY), and the FY2025 annual result was 10.42%, down 340.0% from the prior year.
• FCF Margin came in at 9.11% for Q1 2026 at Avanos Medical, down from 28.36% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 36.36% in Q4 2024 to a low of 9.11% in Q1 2026.
• The 5-year median for FCF Margin is 11.34% (2025), against an average of 8.42%.
• Across the five-year window, FCF Margin slumped 15108 bps in 2022 and surged 3243 bps in 2024, its largest moves.
• Avanos Medical's FCF Margin stood at 24.34% in 2022, then plunged by 84 bps to 3.92% in 2023, then surged by 827 bps to 36.36% in 2024, then dropped by 22 bps to 28.36% in 2025, then plunged by 132 bps to 9.11% in 2026.
• The last three FCF Margin figures came in at 9.11% (Q1 2026), 28.36% (Q4 2025), and 3.94% (Q3 2025), per Business Quant data.